Pharmabiz1h
EMA committee recommends marketing approval for Novartis oral Fabhalta to treat adults living with C3 glomerulopathy
EMA committee recommends marketing approval for Novartis oral Fabhalta to treat adults living with C3 glomerulopathy: Basel Monday, March 3, 2025, 10:00 Hrs [IST] Novartis announc ...
Pharmabiz2h
5th Annual Pharma GMP and Quality Management 2025 to be held in Mumbai on April 24
Pharma GMP and Quality Management 2025 to be held in Mumbai on April 24: Our Bureau, Mumbai Monday, March 3, 2025, 09:00 Hrs [IST] The pharmaceutical industry is underg ...
Pharmabiz3h
DCGI stresses on govt’s commitment to foster digital transformation & capacity-building programmes for MSMEs
DCGI stresses on govt’s commitment to foster digital transformation & capacity-building programmes for MSMEs: Shardul Nautiyal, Mumbai Monday, March 3, 2025, 08:00 Hrs [IST] The ...
Pharmabiz3h
DCC asks expert committee to relook at guidelines for uniform implementation of powers of drug inspectors
Gireesh Babu, New Delhi Monday, March 3, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
India’s VC & PE firms see single specialty healthcare as untapped potential for investment
India’s VC & PE firms see single specialty healthcare as untapped potential for investment: Nandita Vijayasimha, Bengaluru Monday, March 3, 2025, 08:00 Hrs [IST] Venture capital ...
Pharmabiz3h
SPCs to issue public notices against display of discount boards in front of medical shops to attract patients
Peethaambaran Kunnathoor, Chennai Monday, March 3, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
DCC recommends upgradation of guidelines related to samples of spurious, NSQ drugs
DCC recommends upgradation of guidelines related to samples of spurious, NSQ drugs: Gireesh Babu, New Delhi Monday, March 3, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee ...
Pharmabiz1d
ProMIS Neurosciences begins patient dosing in phase 1b PRECISE-AD trial of PMN310 for Alzheimer’s disease
Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...
Pharmabiz1d
ImmunityBio receives US FDA’s regenerative medicine advanced therapy designation for Anktiva and CAR-NK for metastatic pancreatic cancer
Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...
Pharmabiz1d
US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis
US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis: Duarte, California Saturday, March 1, 2025, 16:00 ...
Pharmabiz1d
MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible
MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible: London Saturday, March 1, 2025, 15:00 Hrs [IST] MYndspan, a pioneer in consumer brain health t ...
Pharmabiz1d
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...